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Humanised xenograft models allow for the analysis of human tissue within a physiological environment 
in vivo. However, current models often rely on the angiogenesis and ingrowth of recipient vasculature to 
perfuse tissues, preventing analysis of biological processes and diseases involving human blood vessels. 
This limits the effectiveness of xenografts in replicating human physiology and may lead to issues with 
translating findings into human research. We have designed a xenograft model of human vasculature 
to address this issue. Human subcutaneous fat was cultured in vitro to promote blood vessel outgrowth 
prior to implantation into immunocompromised mice. We demonstrate that implants survived, retained 
human vasculature and anastomosed with the circulatory system of the recipient mouse. Significantly, 
by performing transplants into the ear pinna, this system enabled intravital observation of xenografts 
by multiphoton microscopy, allowing us to visualise the steps leading to vascular cytoadherence of 
erythrocytes infected with the human parasite Plasmodium falciparum. this model represents a useful 
tool for imaging the interactions that occur within human tissues in vivo and permits visualization of 
blood flow and cellular recruitment in a system which is amenable to intervention for various studies in 
basic biology together with drug evaluation and mechanism of action studies.
Xenograft models, in which human cells, tissues or organs are implanted into immunodeficient animal hosts 
have proven to be valuable research tools in recent years1,2. By allowing human tissue to be studied in an in vivo 
environment, these models provide a physiologically relevant method for assessing human diseases that neither 
conventional animal models nor human in vitro studies are able to achieve alone.
A wide array of tissues have been examined in these models including hematopoietic stem cells, liver and 
thymus fragments3, adipose tissue4, testicular tissue5, tumours6 and even human brain organoids7. However, the 
majority of xenografts tend to consist of cells or small organoids as a major challenge of using tissue fragments 
is the re-establishment of blood flow to the grafts. When a tissue is first implanted into an animal, cells within a 
distance of 150–200 µm of a blood vessel survive through molecular diffusion but those cells deeper in the graft 
experience hypoxia and glucose deprivation8. This triggers the release of soluble mediators including vascular 
endothelial growth factor (VEGF) which induce both host and graft endothelial cells (ECs) to initiate angiogene-
sis9. This allows the ECs to self-replicate and form hollow capillary sprouts that continue to grow until they meet 
and connect with another capillary, resulting in the restoration of normal blood flow.
During this process of neovascularisation, the vessels from the host tend to grow into the graft in a process 
known as internal inosculation. This results in a substantial proportion of the graft vasculature originating from 
the host, and a loss of the vasculature of graft origin10,11, limiting the ability to effectively study the function of 
human vasculature within human xenografts12.
Research in a variety of areas would benefit from a xenograft system that would allow non-invasive in vivo 
visualisation of cellular interactions occurring within and around human vasculature. These include research 
examining vascular remodelling and repair, models of acute inflammation as well as various infection studies 
examining the interactions of bacteria or protozoan parasites with human tissue13. A model allowing for the vis-
ualisation of the vascular cytoadherence of Plasmodium falciparum would be particularly useful, as this process 
1Institute of Infection, Immunity & Inflammation, University of Glasgow, Scotland, UK. 2Liverpool School of Tropical 
Medicine, Liverpool, UK. 3Instituto de Medicina Molecular, University of Lisbon, Lisbon, Portugal. *email: james.
brewer@glasgow.ac.uk
open
2Scientific RepoRtS |         (2020) 10:2058  | https://doi.org/10.1038/s41598-020-58650-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
is thought to be a major contributor to a deadly form of disease14, known as cerebral malaria, but cannot be rep-
licated in murine malaria models.
Accordingly, we designed a new model that incorporated human tissue in a site that was minimally invasive 
and allowed for longitudinal imaging: the ear pinna. We demonstrated that by pre-culturing the tissue prior to 
implantation we could promote the retention of human vasculature and the successful re-perfusion of the graft. 
Using the human specific parasite P. falciparum, we validated the function of the model and visualised binding of 
the parasite to the endothelium.
Methods
Mice. NOD SCID Gamma mice (NSG)15 (originally purchased from Jackson Laboratories, Bar Harbor, ME, 
USA) were produced in house (Central Research Facility, University of Glasgow, UK). These mice were bred in a 
sterile film isolator and maintained in individually ventilated cages (IVC). Animals were maintained on a 12-hour 
light/dark cycle and provided with food and water ad libitum. All procedures were performed under a UK Home 
Office licence in accordance with the Animals (Scientific Procedures) Act 1986.
ethical approval. The use of human tissue within this study was approved by the NHS Greater Glasgow 
and Clyde Biorepository (application number 97) on behalf of the NHS Research Ethics Committee. Informed 
consent was obtained from all subjects. All tissue was processed in accordance with the Human Tissue (Scotland) 
Act 2006.
Human tissue. Human tissue was acquired from patients undergoing routine surgery at the Queen Elizabeth 
University Hospital (QEUH), Glasgow, UK. Tissue was collected by the Greater Glasgow and Clyde Biorepository 
on our behalf. The tissue consisted of subcutaneous fat from the breast or abdomen of female patients between the 
ages of 20 and 60 years old. Tissue was only taken from patients not receiving ongoing cancer treatment.
tissue culture. Human subcutaneous fat was stored in Aqix (Life Science Production, UK) prior to culture. 
Under aseptic conditions, small pieces of tissue (3–5mm2) were dissected and 4 pieces placed in each well of a 12 
well plate. Matrigel (400 μl; Corning, NY, USA) was then added to each well and the plate was incubated at 37 °C 
for 30 minutes to polymerise the Matrigel. The wells were then Supplemented with 2 ml of endothelial growth 
medium (EGM) (Promocell, Germany). The plates were incubated at 37 °C in 5% CO2. Media was replaced every 
three days.
ear implant surgery. After 7 days of culture, tissue with more than 0.25 mm of external inosculation around 
the entire outer circumference was implanted into mice (Fig. 1e). All surgical procedures took place in a Category 
2 biological safety cabinet under aseptic conditions. The mice were anaesthetised with oxygen (1.5 L/minute) 
containing 2.5% isoflurane and prophylactically treated with buprenorphine (0.1 mg/kg). The ear was cleaned 
with 70% alcohol. It was then affixed to double sided adhesive tape on the bore of a 5 ml syringe. The ear pinna 
was injected with 50–100 μl of sterile saline to create a pocket. Forceps were then inserted into the ear to create 
an incision, which was enlarged using microdissection scissors. Curved forceps were used to enlarge the pocket 
and separate the skin of the ear pinna. The Matrigel embedded tissue was then inserted into the pocket and the 
incision was sealed using Vetbond glue (3M, MN, USA). Mice were recovered with oxygen before being moved 
to an IVC placed on a heat mat for 1 hour. They were returned to normal housing and monitored daily until the 
implants had fully healed. All experiments were carried out using these mice 21–35 days post-surgery unless 
otherwise stated.
flow cytometry. Comparisons of fresh, cultured and implanted tissues were performed using flow cytome-
try. The tissues were all processed using the same method with some minor changes. Prior to digestion, each well 
containing cultured tissue was incubated with 1 mg/ml dispase II (Thermofisher, Waltham, MA, USA) in Ca2+/
Mg2+ free PBS for 1 hour at 37 °C to dissolve the Matrigel. The tissues in these wells were analysed together and 
the results divided by the number of embedded pieces of tissue in the well. Engrafted mice were culled 21 days 
post-surgery and their implant and control ears removed and placed in RPMI prior to digestion. All other pro-
cessing steps were identical between the different tissue conditions.
Once collected, the tissues were minced and digested in RPMI containing 2% foetal bovine serum (FBS) 
(Thermofisher, Waltham, MA, USA), 1 mg/ml collagenase II ((Sigma Aldrich, Dorset, UK) and 10 U/ml DNase 
(Invitrogen, Carslbad, CA, USA) for 50 minutes at 37 °C under constant agitation. The tissues were processed 
through a 100 µm filter and washed twice in 2% FBS RPMI and once in Ca2+/Mg2+ free PBS containing 2 mM 
EDTA at 400 g for 5 minutes. Blood was not digested. The cell solutions were then suspended in 400 µl Ca2+/
Mg2+ free PBS containing eFluor 506 viability dye (1:1000) (eBiosciences, Waltham, MA, USA) and incubated 
for 20 minutes at 4 °C. This step was omitted in samples examining labelled infected red blood cells. The cells 
were washed in Ca2+/Mg2+ free PBS containing 2 mM EDTA and resuspended in conditioned media from the 
anti-CD16/CD32 antibody producing hybridoma (2.4G2) (FcBlock). To examine human endothelial cells, anti-
body suspensions containing human Fc Block, V450 labelled anti-human CD36 (both from BD Biosciences, San 
Jose, USA), APC-eFluor 780 labelled anti-human CD45, APC labelled anti-mouse CD31, PE labelled anti-human 
CD31, AF700 labelled anti-human CD34 (all from Biolegend, San Diego, CA, USA), PE-Cy7 labelled anti-mouse 
CD45 and PerCP-eFluor 710 labelled anti-human ICAM-1 (both from eBiosciences, Waltham, MA, USA) were 
added to each sample and incubated for 20 minutes at 4 °C. To examine labelled infected red blood cells in vivo, 
antibody suspensions were prepared using PE-Cy7 labelled anti-mouse CD45 as above, APC labelled anti-mouse 
Ter119 (from eBiosciences, Waltham, MA, USA) and, depending upon the experiment, PerCP-Cy5.5 labelled 
anti-human CD235a (from Biolegend, San Diego, CA, USA) and incubated as described above. The cells were 
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subsequently washed and analysed using a BD LSRfortessa flow cytometer (BD Biosciences, San Jose, USA). 
Analysis of flow cytometry data was performed using FlowJo 10 (FlowJo LLC, Ashland, OR, USA).
Histology. Mice were euthanized, and both the implant and controls ears were cut off and placed in 10% 
neutral buffered formalin for 16 hours. The tissue was then dehydrated through different grades of alcohol and 
xylene and embedded in wax. 8μm transverse sections were cut from each tissue and mounted on glass slides. 
They were then stained with haematoxylin and eosin and subsequently imaged on an EVOS Cell Imaging System 
(Thermofisher, Waltham, MA, USA).
Immunofluorescence. Mice were euthanized, and both the implant and controls ears were cut off and 
placed in PBS. Using forceps, the skin on the ventral side of the ear was retracted to expose the human tissue 
implant. The ears were fixed in 4% paraformaldehyde for 20 minutes at 4 °C and incubated overnight in 0.05% 
Triton X-100 in PBS containing anti-human CD31 (Biolegend, San Diego, CA, USA) antibody conjugated to 
either PE or AF647 in a 1:200 dilution. The tissue was washed in PBS and mounted on a glass slide with a glass 
coverslip for imaging.
parasites. P. falciparum was cultured as described previously16,17. Cultures were grown in RPMI-1640 
Supplemented with 24 mM sodium bicarbonate (Sigma-Aldrich, St Louis, MO, USA) and 10% human serum 
(Interstate Blood Bank Inc, Memphis, TN, USA). They were gassed with 5% CO2/1% O2 and 94% N2 mixture and 
maintained at 37 °C. The ICAM-1/CD36 binding parasite strain ItG was used throughout18.
Figure 1. Developing a method for implanting human tissue into the ear pinna of immunocompromised mice. 
(a) Schematic of the model. (b) Human subcutaneous fat was collected from routine surgeries and dissected 
into 3–5mm2 sized pieces before being embedded in Matrigel (c) which promoted the outgrowth of blood 
vessels (red arrows). (d) Comparisons of Matrigel embedded versus non Matrigel embedded tissues indicated 
an increase in the number of endothelial cells in embedded tissues. (e) The surgery was performed by (i) affixing 
the ear pinna to a syringe and injecting 50 µl of saline to create a pocket. (ii) A hole was created using forceps. 
(iii) Scissors were inserted in this hole and used to create a flap. (iv) Curved forceps were used to split the skin 
apart to create a larger pocket. (v) The superior skin was retracted and (vi) the human tissue was inserted. (vii) 
The incision was sealed with glue and the mouse recovered. (f,i) Ears implanted with human tissue using a 
previous method23 did not heal well. (ii) Ears implanted with tissue using the new method healed well three 
weeks post-surgery and resembled the (iii) control ear. (d) n = 8, pooled from two independent experiments. 
Statistical analysis was performed using a Mann Whitney test, **p < 0.01.
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Parasites were magnetically purified using CS columns (Miltenyi-Biotech, Bergisch Gladbach, Germany) in 
a SuperMACS II separator (Miltenyi-Biotech, Bergisch Gladbach, Germany) as per manufacturer’s instructions. 
Columns were blocked with 3% BSA for 15 minutes. One 50mm x 9mm petri dish containing 25 ml of parasites, 
maintained at 8–10% parasitaemia at a 5% haematocrit produced approximately 6 × 108 infected RBCs at a purity 
of 80–90%. The parasites were ready to use when in mid/late trophozoites stages. They were washed and resus-
pended in 20 ml of serum free RPMI and added to the column. Once the parasites had run through the column, 
it was washed with 25 ml of serum free RPMI. The column was detached from the magnet and the parasites were 
removed by washing with 50 ml of serum free RPMI.
Labelling red blood cells. Red blood cells (RBCs) with and without parasites were fluorescently labelled 
with CMTPX (Thermofisher, Waltham, MA, USA). All labelling and incubation steps took place at 37 °C under 
constant agitation. RBCs were incubated with CMTPX (5 μM) for 20 minutes. 1 ml of dye was used to stain 1 × 108 
RBCs. Following staining, the RBCs were washed twice at x400 g for 5 minutes and incubated with 10% RPMI 
for 10 minutes. The RBCs were washed a further two times at x400 g for 5 minutes in Ca2+/Mg2+ free PBS and 
resuspended in 100 µl of Ca2+/Mg2+ free PBS.
Static binding assay. On a marked plastic 60 mm × 15 mm petri dish, 2 µl drops of human ICAM-1 (R&D 
Systems, MN, USA), mouse ICAM-1 (R&D Systems, MN, USA) or PBS were added in triplicate around the 
sides of the dish. The dish was placed in a humidity chamber and incubated at 37 °C for 1 hour. The spots were 
then removed, and the dish was blocked in 1% BSA in PBS at 37 °C for 1 hour. A suspension of P. falciparum 
trophozoites at 3% parasitaemia in 1% haematocrit was prepared. 1.25 ml of parasite suspension was added to 
the dish, which was swirled occasionally, for 1 hour at 37 °C. The parasites were gently removed, and the dish was 
gently washed in RPMI 5 times. The bound parasites were then fixed in 1% glutaraldehyde in PBS at room tem-
perature for 20 minutes. Imaging of the dish was performed using an EVOS Cell Imaging System (Thermofisher, 
Waltham, MA, USA). One image was taken in the centre of each spot and the number of bound parasites was 
calculated.
Multiphoton imaging of implants. Multiphoton imaging was performed with a Zeiss LSM7 MP system 
equipped with both a 10x/0.3 NA air and a 20x/1.0NA water immersion objective lens (Zeiss) and a tuneable 
titanium/sapphire solid state 2-photon excitation source (Chamelon Ultra II; Coherent Laser Group) and optical 
parametric oscillator (OPO; Coherent Laser Group). For intravital imaging, mice were given an intravenous 
injection of 20 µg of PE labelled or AF647 labelled anti-human CD31 and 5 µg TNFα in PBS. Following six hours 
of incubation, the mice were injected intravenously with 5 × 108 uninfected unlabelled RBCs and anaesthetised 
with oxygen (1.5 L/minute) containing 2.5% isoflurane. The implant or control ear was affixed to a metal stage 
using veterinary-grade glue (Vetbond; 3M). Silicone grease was used to create a ring around the ear, which was 
then filled with PBS (Supplementary Fig. 4). When under the microscope, mice were given an injection of 5 × 108 
CMTPX labelled infected red blood cells in the tail vein. A laser output of 820 nm with or without an OPO signal 
at 1060 nm provided excitation of adipocytes, hCD31 positive cells and labelled red blood cells. Images were 
acquired with an X-Y pixel resolution of 512 × 512 in a variety of Z increments. For vessel analysis, 5 × 5 tile 
scans of 100 µm stacks were acquired in 4 µm Z stack increments. All images were processed using Volocity 6.1.1 
(Perkin Elmer, Cambridge, UK).
image analysis. Analysis of human blood vessels was performed using images of fresh and implanted human 
tissue from different patients. Between 2 and 3 animals implanted with the same human tissue were used per data 
point for the implanted images. All images were analysed using the Vessel Analysis plugin provided by Fiji. Z 
stacks were first flattened then converted to binary images. The vascular density plugin was then run to produce 
the vascular density and vascular length density measurements. Vessel diameters were measured manually by 
counting five randomly selected vessels in five fields of view in each image.
Analysis of infected RBCs in vivo was performed using Imaris Version 7.6.5. Individual cells were defined as 
objects and tracked in 2D. Track plots demonstrate the movement of cells relative to their point of origin in the 
blood vessels.
Statistical analysis. All graphs and statistical analyses were produced using GraphPad Prism 7 (GraphPad 
Software Inc., San Diego, CA, USA). P values < 0.05 were deemed to be significant.
Results
Developing a method for implanting human tissue into the ear pinna. The basic layout of the xen-
ograft model is shown in Fig. 1a. We focussed specifically on subcutaneous adipose tissue (SAT) for development 
of the model as it is well vascularised and is an important site in both infection and immunity19,20. The tissue is 
also a common by-product of surgery and was therefore readily available for technical optimisation. Although not 
characterised as fully as SAT, we also had limited success implanting dermis, kidney cortex and skeletal muscle 
into the ear pinna as shown from histology studies of the tissues three weeks post-implantation. However, we 
were unable to form stable grafts consisting of brain, duodenum or colon as these tissues underwent major mor-
phological changes upon implantation (Fig. S1).
Initial work examined whether tissue could be implanted directly from patients into the ear pinna of mice. We 
found that these tissues healed poorly and lost a substantial proportion of graft vasculature (data not shown). We 
therefore decided to culture the human tissue prior to implantation to stimulate the outgrowth of blood vessels21. 
To achieve this, tissues were embedded in Matrigel supplemented with endothelial growth medium (Fig. 1b). 
Consistent with previous studies22, this improved the retention of vessels of graft origin (Fig. 1c). Flow cytometric 
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Figure 2. Human vasculature is retained in engrafted tissue. Analysis was performed on fresh, cultured and 
implanted human tissue to determine the effect of engraftment. Histological staining of the (a) implant and (b) 
control ear demonstrated that the human tissue survived implantation. (c) Flow cytometry was performed to 
determine the endothelial cell (EC) content of fresh, cultured (Cult) and implanted (Imp) tissue. n = 5 from five 
independent experiments. Each data point from implanted samples was pooled from 3–4 mice implanted with 
human tissue from the same source. Statistical analysis was performed using a Kruskal-Wallis test, *p < 0.05. 
(d–h) Flow cytometry was performed on implant (Imp), mock surgery (Mock) and control (Con) ears to 
examine the mouse and human ECs populations. 3–4 mice per group, five independent experiments. Statistical 
analysis was performed using a Wilcoxon test, ****p < 0.0001. (i) An intravenous injection of an anti-human 
CD31 antibody confirmed that the engrafted tissue contained human ECs and was perfused. (j) The control ear 
confirmed that the antibody was human specific. Tile scans were taken of (k) fresh and (l) implanted human 
tissue stained with an anti-human CD31 antibody. Images were centred on the core of the tissues but included 
most vessels on the periphery. The changes in the blood vessels were quantitatively measured using a Fiji plugin 
called Vessel Analysis which determined the (m) vascular density, and (n) vascular length density. Blood vessel 
diameters (o) were measured manually by counting five randomly selected blood vessels in five fields of view in 
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analysis of engrafted implants indicated that a significantly higher number of human ECs (Mann-Whitney, 
P < 0.01) were found in Matrigel embedded tissues compared to those cultured without Matrigel (Fig. 1d). This 
confirmed that the pre-treatment improved the retention of the human vasculature in grafts, as shown in previous 
animal engraftment studies22.
Following 7 days of culture, tissues with externally inosculated vessels at least 0.15 mm in length around their 
entire outer circumference were implanted into NSG mice. Our previously described implantation method23 
resulted in poor wound healing with human tissue (Fig. 1fi). We therefore optimised the surgical approach by 
creating a large pocket in the mouse ear pinna (Fig. 1e). To achieve this, sterile saline was first injected into the 
ear pinna to create a subcutaneous pouch (i). Forceps were then placed into the needle entry site to enlarge the 
opening (ii) and an incision was made using scissors (iii). Curved forceps were then used to expand the pouch 
and separate the skin (iv). The skin on the ventral side was retracted (v) and Matrigel embedded SAT was placed 
within the pouch (vi). Finally, the incision was sealed using veterinary grade glue (vii). Following three weeks of 
recovery, the ear pinna had fully healed (Fig. 1fii) and resembled the control ear (Fig. 1fiii) confirming that tissue 
could be successfully engrafted using this method.
Human tissue survives and retains human vasculature following implantation into the ear 
pinna of immunocompromised mice. Having developed a method for implanting human tissue into the 
ear pinna, we next had to determine whether the grafts survived and retained human vasculature. Histological 
analysis of implant (Fig. 2a) and control (Fig. 2b) ears demonstrated that the adipocytes and stroma of the 
transplanted tissue retained their normal structural characteristics and did not form a necrotic core. The grafts 
survived for up to five weeks post-implantation but may survive longer as has been shown in previous human 
engraftment studies4,5. Flow cytometry analysis was performed to identify transplant ECs (mouse CD45− 
(mCD45)/human CD45− (hCD45), mouse CD31− (mCD31)/human CD31+ (hCD31)) in the fresh, cultured 
and implanted human SAT (Fig. S2). Examination of the total number of human ECs indicated that the implants 
contained a significantly higher number of ECs than the fresh tissues (Fig. 2c) (Kruskal-Wallis test, P < 0.05). A 
breakdown of the EC subpopulations indicated few changes in the proportions of ECs expressing the adhesion 
molecules CD34 (Fig. S3A) and ICAM-1 (Fig. S3B) suggesting that the cells had not become activated as a result 
of implantation. However, the percentage of ECs expressing the scavenger marker CD36 (Fig. S3C) was signifi-
cantly lower in implanted tissue suggesting a transplant induced reduction in the subcutaneous microvasculature 
characteristics of the tissue24 (Two-Way ANOVA, P < 0.0001).
Flow cytometry of control, mock surgery (surgery with no tissue implants) and implant ears indicated the 
presence of human ECs in the implant ears only (Fig. 2d). The percentage of mouse EC’s was not significantly 
different between treatments (Fig. 2e) but the number of mouse EC’s was significantly higher in the implant ear 
compared to the control ear (Fig. 2f) (Wilcoxon Test, P < 0.0001). The number of cells were similar to those 
observed in the mock surgery ear suggesting that the increase was related to healing in response to surgery. By 
contrast, the percentage (Fig. 2g) and number (Fig. 2h) of human ECs were found to be significantly increased 
in the implant ears compared to the control ears (Wilcoxon Test, P < 0.0001) and were completely absent in the 
mock surgery control. This confirmed that the human ECs had been retained and had expanded in the implant 
ear following surgery.
To definitively confirm that the tissues had successfully anastomosed with the recipient mouse vasculature, 
we intravenously injected engrafted mice with a human specific αCD31 antibody. After one hour, we culled the 
mouse and imaged the tissue using multiphoton microscopy. Analysis of these images clearly demonstrated that 
the implanted tissues contained human blood vessels (Fig. 2i) whereas no human vessels were detected in the 
mouse control ears (Fig. 2j).
Further analysis of the vasculature of hCD31 labelled fresh (Fig. 2k) and implanted (Fig. 2l) tissues indi-
cated significantly higher vascular densities (Fig. 2m) and vascular length densities (Fig. 2o) in the implanted 
tissue (Unpaired T test, P < 0.05) particularly around the periphery of the graft (Fig. S4), as per previous engraft-
ment research25. Similarly, the blood vessel diameters (Fig. 2n) were also found to be significantly larger in the 
implanted tissue suggesting a reduction in the microvasculature as shown by flow cytometry (Fig. S3C). The 
human vasculature was present for up to five weeks in our study. Although we did not examine later time points 
we would expect it to survive longer as shown with previous human EC engraftment studies26.
tracking labelled red blood cells in vivo. To image the intravascular behaviours of P. falciparum to 
human endothelium, we selected an ICAM-1 binding parasite known as ItG18. From our flow cytometry data 
(Fig. S3B) we knew that ICAM-1 was widely expressed on the human ECs and that this expression of this receptor 
could be increased by pre-treatment with TNFα (Fig. 3a). Using in vitro static binding assays, we confirmed that 
the parasite specifically bound to human recombinant ICAM-1 and not the mouse homologue (Fig. 3b), confirm-
ing that the parasite would only bind to human endothelium and was therefore suitable for our study.
Parasites were purified in the trophozoite stage of their lifecycle and labelled with the intracellular fluorescent 
dye, CMTPX (Fig. 3c). Following injection, we determined the circulation time of the parasite infected (iRBCs) 
and uninfected (uRBCs) red blood cells by taking regular blood samples over an hour and quantifying cell num-
ber by flow cytometry (Fig. 3d). This indicated that the parasites had a short circulation time, being cleared from 
the blood entirely within 20 minutes of the initial injection (Fig. 3e). However, we found that we could extend the 
each image. n = 3 from three independent experiments. Each data point from implanted samples was pooled 
from 2–3 mice implanted with human tissue from the same source. Statistical analysis was performed using an 
unpaired T test, *p < 0.05, **p < 0.01.
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circulation time of the labelled cells by giving a pre-injection of 5 × 109 unlabelled uRBCs to saturate the mouse 
macrophages that were responsible for removing the cells27 (Fig. 3f). This allowed approximately 20,000 labelled 
RBCs to remain in the circulation throughout the imaging period allowing us to perform intravital imaging 
studies.
P. falciparum cytoadherence can be observed in human blood vessels. After confirming that the 
P. falciparum parasite could bind to human ICAM-1 in vitro, we began intravital imaging studies (Fig. S5). Prior 
to imaging labelled RBCs, mice were pre-treated with unlabelled uRBCs to increase circulation time, TNFα 
to enhance ICAM-1 expression on transplants and finally a fluorescently labelled human anti-CD31 antibody 
to identify human blood vessels in vivo, following the protocols established above. Mice were then injected 
intravenously with labelled iRBCs and a multiphoton microscope was used to image the cells interacting with 
the labelled human vasculature. Several behaviours associated with cytoadherence were observed including 
cell tethering and rolling (Fig. 4a, Supplementary Video 1), adherence of iRBCs to blood vessel walls (Fig. 4b, 
Supplementary Video 2), blood vessel occlusion (Supplementary Video 2) and collections of iRBC around blood 
vessel junctions (Fig. 4c, Supplementary Video 3). An example of the analysis we could perform on the circulating 
iRBCs indicated differences in the speed of cells as they sequestered in blood vessels (Fig. 4d). Sequestration was 
confirmed to be specific to human blood vessels through flow cytometry (Figs. S6, 4e,f), which shown a signifi-
cantly higher number of iRBCs in the implant ear compared to the control ear (Paired T Test, P < 0.05).
Figure 3. Tracking labelled red blood cells in vivo. (a) Human endothelial cell ICAM-1 expression was induced 
by intravenously injecting engrafted mice with human TNFα (5 μg/mouse) 6 hours before they were culled. 
Control mice received PBS alone. n = 4, one independent experiment. Statistical analysis was performed using 
a Mann-Whitney test, *p < 0.05. (b) The P. falciparum parasite, ItG, was shown to bind specifically to human 
recombinant ICAM-1 using in vitro binding assays. n = 3, one independent experiment. Statistical analysis was 
performed using a Two-Way ANOVA with Tukey’s multiple comparisons, ****p < 0.0001. (c) Infected and 
uninfected RBCs were labelled with CMTPX. (d–f) RBCs were injected intravenously into mice with human 
tissue implants and their depletion from the circulation was assessed by flow cytometry. The number of CMPTX 
labelled uninfected and infected RBCs was assessed without (e) and with (f) a pre-injection of unlabelled, 
uninfected RBCs. n = 4, one independent experiment.
8Scientific RepoRtS |         (2020) 10:2058  | https://doi.org/10.1038/s41598-020-58650-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
Discussion
Here, we describe a novel method for culturing and implanting human tissue that promotes the retention and 
expansion of human vasculature. This system is potentially more biologically relevant than current animal xeno-
graft models, allowing the study and direct observation of human vasculature in vivo and the interactions of cells 
Figure 4. P. falciparum cytoadherence can be observed in human blood vessels. Intravital imaging was 
performed using a multiphoton microscope. Mice were pre-treated with TNFα, unlabelled, uninfected RBCs, 
and AF647 labelled anti-human CD31 antibody. Labelled iRBCs were then injected into the tail vein of the mice. 
(a) Tethering and rolling (b) adherence of iRBCs to blood vessel walls (c) and collections of iRBCs around blood 
vessel junctions were all observed. n = 3, three independent experiments. (d) An example of imaging analysis 
indicated differences in the speed of sequestering cells over time in two different iRBCs (i & ii). Arrow indicates 
direction of blood flow. Rainbow bar indicates speed of iRBC in blood vessel. Flow cytometry was performed 
on the (e)(i) implant and (ii) control ears to compare the (f) number of iRBCs in the tissues. n = 4, from one 
independent experiment. Statistical analysis was performed using a paired T test, *p < 0.05.
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and molecules in vascular processes and diseases. As an example, we demonstrate the application of this approach 
to the study of Plasmodium parasites whose interactions with human vasculature are central to infection associ-
ated disease processes.
A key step in maintaining human vasculature in xenografts was to pre-culture tissue in an angiogenic extra-
cellular matrix. This promoted the formation of capillary sprouts and the outgrowth of blood vessels prior to 
implantation21. Previous studies found that this significantly improved the retention of blood vessels of graft 
origin in murine allografts22, however, to the best of our knowledge, this is the first time this has been applied in 
human xenografts.
Alternative models which employ the use of human endothelial cells lines, such as human umbilical vein 
endothelial cells (HUVECs), to form microvascular networks have been used extensively to study blood vessel 
development in vivo26 but have several drawbacks. These cell lines lack the heterogeneity of ECs and do not 
account for differences in cell phenotype, which vary greatly depending upon the cells local microenvironment, 
state of activation and exposure to soluble mediators28. Furthermore, the cell lines often lack or have variable lev-
els of many common EC markers including CD34, CD36 and von-Willebrand factor29,30 which limits their ability 
to model the vasculature in different tissues. Our model overcomes these problems by maintaining the grafts 
endogenous vasculature allowing it to more closely resemble human tissue in its natural state.
Once the grafts were perfused, we noticed few changes in vascularisation between tissues used at different 
time points post-implantation. This suggested that the vascularisation was physiological and was not persistent 
and unresolved as is observed with pathological vascularisation. In line with previous studies, the ECs in the 
grafts were shown to have few phenotypic changes following culture and implantation31. However, we did observe 
a decrease in CD36 expression in implanted tissue, a marker that is particularly enriched in the microvasculature 
of SAT32. The decrease in CD36 expression in the flow cytometry data, alongside the increased vascular diameters 
suggested a loss of microvasculature in the grafts. We hypothesise that this may be due to changes in the micro-
vascular organisation around the periphery of the graft.
The choice of the ear pinna as an engraftment site had several benefits over other imaging methods, particu-
larly imaging windows33. As the ear could be imaged without surgical exposure, we were able to perform intravital 
imaging of the mice over an extended period of time. This not only reduced the stress that the animal was under 
but also allowed for the same engrafted animal to be imaged repeatedly, resulting in a significant reduction in the 
number of animals required for experiments.
Using this method, we chose to examine cytoadherence of the human malarial parasite P. falciparum to human 
endothelium. This is a process that cannot be observed in murine Plasmodium infections due to the specific 
properties of the human-infective parasite34. Using our model, we were able to observe the behaviours associated 
with cytoadherence including rolling, adherence and vessel occlusion35. The ItG parasite used in this study was 
panned on ICAM-1 but was also capable of binding to CD36. As mentioned CD36 expression was downregulated 
in our ECs following implantation, which may have interfered with the ability of the parasites to sequester in the 
blood vessels. However, the level of ligand expression on the EC surface required for cytoadherence is unclear. 
Furthermore, although CD36 is the major adherence receptor in experimental cerebral malaria, it is not clinically 
significant in the human form of the disease as the adhesion protein on the surface of iRBCs, PfEMP-1, is capable 
of binding to a large number of receptors and is most associated with endothelial protein C receptor (EPCR)36. 
This suggests that the impact of reduced CD36 expression would be minimal for studying other parasite strains 
using this model.
Previous xenograft models37,38 have utilised skin in P. falciparum research, however, this tissue is not recog-
nised as a particularly significant site of parasite sequestration and cytoadherence39,40. By contrast, blood vessels 
in SAT are a more prominent site of parasite sequestration and previous studies have investigated this tissue as 
a model to study molecular processes leading to cytoadherence in brain vasculature41. For these reasons, we 
focussed on transplantation of human SAT, however, a range of other tissues were also found to be compatible 
with the culturing and implantation method. The only tissues we were unable to successfully engraft were those 
that came from the digestive tract or brain. The ability to transplant a variety of tissues, including SAT, there-
fore makes our current approach more flexible and better suited to studying the molecular processes of parasite 
cytoadherence in vivo.
It is notoriously difficult to reconstitute human RBCs in mice due to their rapid removal from the circulation 
by splenic macrophages27. In our model, we overcame this issue by giving the mice a pre-injection of uRBCs 
to saturate the macrophages, allowing us to extend the imaging window for our intravital work. An alternative 
method would have been to deplete the macrophages in advance using clodronate liposomes42; however, due to 
the severely immunocompromised state of our mice we decided against this method due to welfare concerns.
Although this imaging work is preliminary, the model holds great potential in further assessing the behav-
iours of parasites, including P. falciparum, trypanosomes and schistosomes, as well as bacterial infections such as 
Neisseria meningitidis, which are all known to mediate effects in both the skin and adipose tissue in patients13,43. 
Aside from infection research, the model could also be further adapted to include components of a human 
immune system, either through the transfer of peripheral blood mononuclear cells (PBMCs) or the transplan-
tation of haematopoietic stem cells, which is a feature often incorporated into humanised models44. This would 
allow us to visualise various aspects of immune cell behaviours, including extravasation, in real time using acute 
models of inflammation. Other applications in which a model of human vasculature would also be useful include 
diagnostic imaging in cardiovascular research45 and drug screening in cancer studies12.
In summary, we have developed a humanised xenograft model in the ear pinna of immunocompromised 
mice. This model retains the tissues endogenous human vasculature allowing for non-invasive longitudinal imag-
ing of blood flow and cellular recruitment in a system that can be easily adapted to study a variety of different 
biological processes.
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